(Q70082352)

English

Enhancement of Glucantime therapy of murine Leishmania donovani infection by a synthetic immunopotentiating compound (CP-46,665-1)

scientific article published on 01 March 1985

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

3985270

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3985270%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 October 2019

title

Enhancement of Glucantime therapy of murine Leishmania donovani infection by a synthetic immunopotentiating compound (CP-46,665-1) (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

3985270

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3985270%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

Leishmania donovani

1 reference

L E Adinolfi

1

1 reference

stated in

Europe PubMed Central

PubMed ID

3985270

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3985270%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 October 2019

P F Bonventre

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

3985270

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3985270%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 October 2019

language of work or name

English

0 references

publication date

1 March 1985

1 reference

stated in

Europe PubMed Central

PubMed ID

3985270

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3985270%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 October 2019

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

American Journal of Tropical Medicine and Hygiene

1 reference

stated in

Europe PubMed Central

PubMed ID

3985270

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3985270%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 October 2019

volume

34

1 reference

stated in

Europe PubMed Central

PubMed ID

3985270

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3985270%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 October 2019

issue

2

1 reference

stated in

Europe PubMed Central

PubMed ID

3985270

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3985270%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 October 2019

page(s)

270-277

1 reference

stated in

Europe PubMed Central

PubMed ID

3985270

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3985270%20AND%20SRC:MED&resulttype=core&format=json

retrieved

8 October 2019

Identifiers

DOI

10.4269/AJTMH.1985.34.270

1 reference

stated in

Europe PubMed Central

PubMed ID

3985270

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3985270%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference

Europe PubMed Central

PubMed ID

3985270

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3985270%20AND%20SRC:MED&resulttype=core&format=json

(Q70082352)

Enhancement of Glucantime therapy of murine Leishmania donovani infection by a synthetic immunopotentiating compound (CP-46,665-1)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)